Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review
Authors
Keywords
-
Journal
Current Psychiatry Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-12
DOI
10.1007/s11920-022-01361-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
- (2022) Natalie Gukasyan et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
- (2021) Nakul Ravi Raval et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: a systematic review
- (2021) Bruno Romeo et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Self-blinding citizen science to explore psychedelic microdosing
- (2021) Balázs Szigeti et al. eLife
- The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
- (2021) Rafael Guimarães dos Santos et al. Risk Management and Healthcare Policy
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
- (2021) Natalie Hesselgrave et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Journal of Affective Disorders Dose Effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis
- (2021) Nan-Xi Li et al. JOURNAL OF AFFECTIVE DISORDERS
- Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis
- (2021) Robert F Leger et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells
- (2021) Sanah Malomile Nkadimeng et al. Journal of Inflammation Research
- Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression
- (2020) Meghan Hibicke et al. ACS Chemical Neuroscience
- Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
- (2020) Lea J Mertens et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis
- (2020) Simon B. Goldberg et al. PSYCHIATRY RESEARCH
- Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
- (2020) Fiammetta Cosci et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Reward-Processing Behavior in Depressed Participants Relative to Healthy Volunteers
- (2020) D. Chamith Halahakoon et al. JAMA Psychiatry
- Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice
- (2020) Joanes Grandjean et al. NEUROIMAGE
- Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases—A Systematic Review and Meta-Analysis of Clinical Trials
- (2020) Ana Sofia Vargas et al. Biomedicines
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
- (2019) Martin K. Madsen et al. NEUROPSYCHOPHARMACOLOGY
- Classical psychedelics for the treatment of depression and anxiety: A systematic review
- (2019) Silvia Muttoni et al. JOURNAL OF AFFECTIVE DISORDERS
- Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms
- (2019) Rafael Guimarães dos Santos et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Effects of psilocybin therapy on personality structure
- (2018) D. Erritzoe et al. ACTA PSYCHIATRICA SCANDINAVICA
- The hidden therapist: evidence for a central role of music in psychedelic therapy
- (2018) Mendel Kaelen et al. PSYCHOPHARMACOLOGY
- Psychedelics Promote Structural and Functional Neural Plasticity
- (2018) Calvin Ly et al. Cell Reports
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
- (2017) Leor Roseman et al. NEUROPHARMACOLOGY
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
- (2017) Robin L Carhart-Harris et al. Scientific Reports
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
- (2016) Sagar V. Parikh et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience
- (2016) Thomas Pokorny et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Classical hallucinogens and neuroimaging: A systematic review of human studies
- (2016) Rafael G. dos Santos et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Long-term follow-up of psilocybin-facilitated smoking cessation
- (2016) Matthew W. Johnson et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats
- (2015) Yuichi Sakashita et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers
- (2015) Rainer Kraehenmann et al. BIOLOGICAL PSYCHIATRY
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
- (2014) Bradley N. Gaynes et al. PSYCHIATRIC SERVICES
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
- (2012) R. L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
- (2010) Erich Studerus et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
- (2010) Franz X. Vollenweider et al. NATURE REVIEWS NEUROSCIENCE
- The GRID-HAMD: standardization of the Hamilton Depression Rating Scale
- (2009) Janet B.W. Williams et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started